Oxidative stress and coxsackievirus infections as mediators of beta cell damage: A review

Scientific Research and Essays

Volumn 4, Issue 2, 2008, Pages 042-058

  Sharma, Vibha ^a   Kalim, Shahina ^b   Srivastava, Manoj K ^b   Nanda, Surabhi ^a   Mishra, Sanjay ^a,c  

^a Department of Biotechnology   (India)

^b BUNDELKHAND UNIVERSITY   (India)

^c Department of Biotechnology and Microbiology   (India)

Author keywords

Beta cells; Coxsackievirus infection; Human leukocyte antigen; Oxidative stress; Type 1 diabetes

Indexed keywords

COXSACKIEVIRUS; ENTEROVIRUS;

EID: 70349216373     PISSN: None     EISSN: 19922248     Source Type: Journal    
DOI: None     Document Type: Review

References (220)

1. Adachi K, Muraishi A, Seki Y, Yamaki K, Yoshizuka M (1996). Coxsackievirus B3 genomes detected by polymerase chain reaction: evidence of latent persistency in the myocardium in experimental murine myocarditis. Histol. Histopathol. 11: 587-596.
2. Afonso CL, Neilan JG, Kutish GF, Rock DL (1996). An African swine fever virus Bc1-2 homolog, 5-HL, suppresses apoptotic cell death. J. Virol. 70; 4858-4863.
3. Agol VI, Belov GA, Bienz K, Egger D, Kolesnikova MS, Raikhlin NT, Romanova LI, Smirnova EA Tolskaya EA (1998). Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis but not cytopathic effect. Virolology 252, 343-353.
4. Ahmad S, Alsayed Y, Druker BJ, Platanias LC (1997). The Type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J. Biol. Chem. 272: 29991-29994.
5. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM, Dietzschold B, Maeda H (1996). Pathogenesis of influenza virus- induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 93: 2448-2453.
6. Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S (1998) Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am. J. Clin. Nutr. 67: 143-147.
7. Ames BN, Cathcart R, Schwiers E, Hochstein P (1981). Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA. 78: 6858-6862.
8. Anastasi E, Santangelo C, Bulotta A, Dotta F, Argenti B, Mincione C, Gulino A, Maroder M, Perfetti R, Di Mario U (2005). The acquisition of an insulin - secreting phenotype by HGF - treated rat pancreatic ductal cells (ARIP) is associated with the development of susceptibility to cytokine - induced apoptosis J. Mole. Endocrinol. 34: 367-376.
9. Anderson ME (1998). Glutathione: an overview of biosynthesis and modulation. Chem. Bio. Interact. 111-112, 1-14.
10. Andreoletti L, Hober D, Becquart P, Belaich S, Copin MC, Lambert V, Wattre P (1997). Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection. J. Med. Virol. 52: 206-214.
11. Armitage RJ (1994). Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin. Immunol. 6: 407-413.
12. Armstrong JS, Jones DP (2002). Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells. FASEB J. 16: 1263-1265.
13. Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW, Peehl DM, Knox SJ (2002). Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ. 9: 252-263.
14. Arnesjo B, Eden T, Ihse I, Nordenfelt E, Ursing B (1976). Enterovirus infections in acute pancreatitis - a possible etiological connection. Scand. J. Gastroenterol. 11: 645-649.
15. Aruoma OI (1998). Free radicals, oxidative stress and antioxidants in human health and disease. J. Am. Chem. Soc. 75: 448-456.
16. Ashkenazi A, Dixit VM (1998). Death receptors: signaling and modulalation. Science 281: 1305-1308.
17. Atkinson MA, Maclaren NK (1994). The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331: 1428-1436.
18. Augstein P, Wachlin G, Berg S, Bahr J, Salzsieder C, Hehmke B, Heinke P, Salzsieder E (2003). Surface and intracellular Fas expression associated with cytokine- induced apoptosis in rodent islet and insulinoma cells. J. Mol. Endocrinol. 30: 163-171.
19. Babior BM (1978a). Oxygen-dependent microbial killing by phagocytes (first of two parts). N. Engl. J. Med. 298: 659-668.
20. Babior BM (1978b). Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl. J. Med. 298: 721-725.
21. Babior BM (2000). Phagocytes and oxidative stress. Am. J. Med. 109: 33-44. 245, 229-240.
22. Bach JF (1994). Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15: 516-542.
23. Baker SJ, Reddy EP (1998). Modulation of life and death by the TNF receptor superfamily. Oncogene 17: 3261-3270.
24. Balavoine GG, Geletii YV (1999). Peroxynitrite scavenging by different antioxidants. Part I: convenient assay. Nitric Oxide 3: 40-54.
25. Banatvala JE, Bryant J, Schernthaner G, Borkenstein M, Schober E, Brown D, De Silva LM, Menser MA, Silink M (1985). Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1: 1409-1412.
26. Banki K, Hutter E, Gonchoroff NJ, Perl A (1998). Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J. Biol. Chem. 273: 11944-11953.
27. Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR, Barber GN (2000). Alpha/Beta Interferons Potentiate Virus-Induced Apoptosis through Activation of the FADD/Caspase-8 Death Signaling Pathway. J. Virol. 74: 1513-1523.
28. Bannister WH, Federici G, Heath JK, Bannister JV (1986). Antioxidant systems in tumour cells: the levels of antioxidant enzymes, ferritin, and total iron in a human hepatoma cell line. Free Radic Res. Commun. 1: 361-367.
29. Bargonetti J, Reynisdottir I, Friedman PN, Prives C (1992). Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant Genes Dev. 53(6): 1886-1898.
30. Baruchel S, Wainberg MA (1992). The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J. Leukoc. Biol. 52: 111-114.
31. Bast A, Wolf G, Oberbaumer I, Walther R (2002). Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diebeteologia 45: 867-876.
32. Beck MA, Chapman NM, McManus BM, Mullican JC, Tracy S. (1990) Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects. Am. J. Pathol. 136: 669-681.
33. Beck MA (1997). Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency. J. Nutr. 127: 966S-970S.
34. Becker BF (1993). Towards the physiological function of uric acid. Free Radic. Biol. Med. 14: 615-631.
35. Beckman JS, Koppenol WH (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271: C1424-1437.
36. Bendelac A, Carnaud C, Boitard C, Bach JF (1987). Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt- 2+ T cells. J Exp. Med. 166: 823-832.
37. Bendig JW, Fleming DM (1996). Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales. Commun. Dis. Rep. CDR. Rev. 6: R81-86.
38. Bennett ST, Lucassen AM, Gough SC, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F (1995). Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat. Genet. 9: 284-292.
39. Benzie IF (2000). Evolution of antioxidant defence mechanisms. Eur. J. Nutr. 39: 53-61.
40. Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW (1995). Coxsackievirus B3 adapted to growth in RD cells binds to decay- accelerating factor (CD55). J. Virol. 69: 1903-1906.
41. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Sci. 275: 1320-1323.
42. Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, Wickham T, Crowell RL, Finberg RW (1998). The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J. Virol. 72: 415-419.
43. Bottino R, Balamurugan AN, Bertera S, Pietropaolo M, Trucco M, Piganelli JD (2002). Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes 51: 2561-2567.
44. Bose S, Banerjee AK (2003). Innate immune response against nonsegmented negative strand RNA viruses. J. Interferon Cytokine Res. 23: 401-412.
45. Buettner GR (1993). The pecking order of free radicals and antioxidants: lipid peroxidation, alphatocopherol, and ascorbate. Arch. Biochem. Biophys. 300: 535-543.
46. Buja LM, Eigenbrodt ML, Eigenbrodt EH (1993). Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch. Pathol. Lab. Med. 117: 1208-1214.
47. Burdon RH, Rice-Evans C (1989). Free radicals and the regulation of mammalian cell proliferation. Free Radic. Res. Commun. 6: 345-358.
48. Campbell RD, Trowsdale J (1993). Map of the human MHC. Immunol. Today 14: 349-352.
49. Cardozo AK, Heimberg H, Heremans Y, Leeman R, Kutlu B, Kruhoffer M, Orntoft T, Eizirik DL (2001). A comprehensive analysis of cytokine-induced and nuclear factor-kappa B- dependent genes in primary rat pancreatic beta-cells. J. Biol. Chem. 276: 48879-48886.
50. Carthy CM, Granville DJ, Watson KA, Anderson DR, Wilson JE, Yang D, Hunt DW, McManus BM (1998). Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J. Virol. 72: 7669-7675.
51. Cerutti PA, Trump BF (1991). Inflammation and oxidative stress in carcinogenesis. Cancer Cells 3: 1-7.
52. Chakrabarti D, Huang X, Beck J, Henrich J, McFarland N, James RF, Stewart TA (1996). Control of islet intercellular adhesion molecule-1 expression by interferon-alpha and hypoxia. Diabetes 45: 1336-1343.
53. Chaudhri G, Clark IA, Hunt NH, Cowden WB, Ceredig R (1986). Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J. Immunol. 137: 2646-2652.
54. Chehadeh W, Kerr-Conte J, Pattou F, Alm G, Lefebvre J, Wattre P, Hober D (2000). Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J. Virol. 74: 10153-10164.
55. Chen G, Branton PE, Yang E, Korsmeyer SJ, Shore GC (1996). Adenovirus E1B 19- Da death suppressor protein interacts with Bax but not with Bad. J. Biol. Chem. 271: 24221-24225.
56. Chiou CC, Liu WT, Chen SJ, Soong WJ, Wu KG, Tang RB, Hwang B (1998). Coxsackievirus B1 infection in infants less than 2 months of age. Am. J. Perinatol. 15: 155-159.
57. Colasanti M, Persichini T, Venturini G, Ascenzi P (1999). S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide. IUBMB Life 48: 25-31.
58. Conaldi PG, Biancone L, Bottelli A, De Martino A, Camussi G, Toniolo A (1997a). Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells. J. Virol. 71: 9180-9187.
59. Conaldi PG, Serra C, Mossa A, Falcone V, Basolo F, Camussi G, Dolei A, Toniolo (1997b). Persistent infection of human vascular endothelial cells by group B coxsackieviruses. J. Infect. Dis. 175: 693-696.
60. Dahlquist G, Blom L, Holmgren G, Hagglof B, Larsson Y, Sterky G, Wall S (1985). The epidemiology of diabetes in Swedish children 0-14 years--a six-year prospective study. Diabetologia 28: 802-808.
61. Dahlquist GG, Ivarsson S, Lindberg B, Forsgren M (1995). Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes 44: 408-413.
62. Darnell Jr JE, Kerr IM, Stark GR (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular proteins. Science 264: 1415-1420.
63. Datta K, Babbar P, Srivastava T, Sinha S, Chattopadhyay P (2002). p. 53 dependent apoptosis in glioma cell lines in response to hydrogen peroxide induced oxidative stress. Int. J. Biochem. Cell Biol. 34: 148-157.
64. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farral M, Barnett AH, Bain SC, Todd JA (1994). A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371: 130-136.
65. Davies JM (1997). Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol. Cell Biol. 75: 113-126.
66. Debbas M, White E (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7: 546-554.
67. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL (1997). Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinol.138: 2610-2614.
68. Deneke SM, Fanburg BL (1989). Regulation of cellular glutathione. Am. J. Physiol. 257: L163-173.
69. Di Meo S, Venditti P (2001). Mitochondria in exercise-induced oxidative stress. Biol. Signals Recept 10: 125-140.
70. DiGuiseppi J, Fridovich I (1984). The toxicology of molecular oxygen. Crit. Rev. Toxicol. 12: 315-342.
71. Dobner T, Horikoshi N, Rubenwolf S, Shenk T (1996). Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272: 1470-1473.
72. Dorman JS, Bunker CH (2000). HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review. Epidemiol. Rev. 22: 218-227.
73. Dypbukt JM, Ankarcrona M, Burkitt M, Sjoholm A, Strom K, Orrenius S, Nicotera P (1994). Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. The role of intracellular polyamines. J. Biol. Chem. 269: 30553-30560.
74. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N (1996). The harmony of the pheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39: 875-890.
75. Eizirik DL, Mandrup-Poulsen T (2001). A choice of death--the signal- transduction of immunemediated beta-cell apoptosis. Diabetologia 44: 2115-2133.
76. Fehsel K, Kolb-Bachofen V, Kroncke KD (2003). Necrosis Is the Predominant Type of Islet Cell Death During Development of Insulin- Dependent Diabetes Mellitus in BB Rats. Lab Invest 83: 549-559.
77. Fernandez-Checa JC, Garcia-Ruiz C, Colell A, Morales A, Mari M, Miranda M, Ardit E (1998). Oxidative stress: role of mitochondria and protection by glutathione. Biofactors 8: 7-11.
78. Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK, Tysoe SA, Wolosker H, Baranano DE, Dore S, Poss KD, Snyder SH (1999). Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat. Cell Biol. 1: 152-157.
79. Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL (2002). Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 76: 4430-4440.
80. Fleury C, Mignotte B, Vayssiere JL (2002). Mitochondrial reactive oxygen species in cell deathsignaling. Biochimie 84: 131-141.
81. Forman HJ (1982). Free radicals in biology. Pyor, W.A., editor. Academic Press New York. p. 65-90.
82. Foulis AK, Farquharson MA, Cameron SO, McGill M, Schonke H, Kandolf R (1990). A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia. 33: 290-8.
83. Fridovich I (1995). Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64: 97-112.
84. Fridovich I (1998). Oxygen toxicity: a radical explanation. J. Exp. Biol. 201(Pt 8): 1203-1209.
85. Fridovich I (1999). Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann. NY Acad. Sci. 893: 13-18.
86. Frisk G, Nilsson E, Tuvemo T, Friman G, Diderholm H (1992). The possible role of Coxsackie A and echo viruses in the pathogenesis of type I diabetes mellitus studied by IgM analysis. J. Infect. 24: 13-22.
87. Froelich CJ, Dixit VM, Yang X (1998). Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. Immonol. today 19: 30-36.
88. Gauntt C, Huber S (2003). Coxsackievirus experimental heart diseases. Front Biosci 8, E23-35.
89. Gepts, W. (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619-633.
90. Girard S, Couderc T, Destombes J, Thiesson D, Delpeyroux F, Blondel B (1999). Poliovirus induces apoptosis in the mouse central nervous system. J. Virol. 73: 6066-6072.
91. Goldstaub D, Gradi A, Bercovitch Z, Grosmann Z, Nophar Y, Luria S, Sonenberg N, Kahana C (2000). Poliovirus 2A protease induces apoptotic cell death. Mol. Cell Biol. 20: 1271-1277.
92. Grankvist K, Marklund SL, Taljedal IB (1981). CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem. J. 199: 393-398.
93. Griffith OW, Mulcahy RT (1999). The enzymes of glutathione synthesis: gammaglutamylcysteine synthetase. Adv Enzymol Relat. Areas Mol. Biol. 73: 209-267.
94. Haber CA, Lam TK, Yu Z (2003). N-acetylcysteine and taurine prevent hyperglycaemia-induced insulin resistance in vivo possible role of oxidative stress. Am. J. Physiol. Endocrinol. Metab. 285: 744-753.
95. Hampton MB, Orrenius S (1997). Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett 414: 552- 556.
96. Hanafusa T, Sugihara S, Fujino-Kurihara H, Miyagawa J, Miyazaki A, Yoshioka T, Yamada K, Nakajima H, Asakawa H, Kono N (1988). Induction of insulitis by adoptive transfer with L3T4+Lyt2- T-lymphocytes in T-lymphocyte-depleted NOD mice. Diabetes 37: 204-208.
97. Havivi E, Baron H, Reshef A, Stein P, Raz I (1991). Vitamins and trace metals status in non insulin dependent diabetes. Int. J. Vitam. Nutr. Res. 61: 328-333.
98. Heimberg H, Nagy ZP, Somers G, De Leeuw I, Schuit FC (1992). Complementation of HLA-DQA and -DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus. Hum. Immunol. 33: 10-17.
99. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik DL (2001). Inhibition of cytokine-induced NF-kappaB activation by adenovirus- mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes 50: 2219-2224.
100. Hengartner MO (2000). The biochemistry of apoptosis. Nature 407: 770-776.
101. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I, Geuskens M, Kroemer G (1997). The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15: 1573-1581.
102. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS, Christie I, Ganser G, Van Dyke K (2002). Nitrosative stress, uric Acid, and peripheral nerve function in early type 1 diabetes. Diabetes 51: 2817-2825.
103. Holmgren A (1985). Thioredoxin. Annu. Rev. Biochem. 54: 237-271.
104. Hoorens A, Stange G, Pavlovic D, Pipeleers D (2001). Distinction between interleukin-1-induced necrosis and apoptosis of islet cells. Diabetes 50: 551-557.
105. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N (1998). Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. NatMed 4: 781-785.
106. Horwitz MS, Sarvetnick N (1999). Viruses, host responses, and autoimmunity. Immunol. Rev.169: 241-53.
107. Horvitz HR (1999). Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res. 59: 1701s-1706s.
108. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N (2002). Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest. 109: 79- 87.
109. Hotta M, Tashiro F, Ikegami H, Niwa H, Ogihara T, Yodoi J, Miyazaki J (1998). Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J. Exp. Med. 188: 1445-1451.
110. Hunt N (1994). Redox mechanisms in T-cell activation. In: "Oxidative Stress, Cell Activation and Viral Infection" (eds. C. Pasquier et al.), Birkhäuser Verlag Basel, Switzerland. pp. 237-251.
111. Hyypiä T, Hovi T, Knowles NJ, Stanway G (1997). Classification of enteroviruses based on molecular and biological properties. J. Gen. Virol. 78: 1-11.
112. Itagaki A, Ishihara J, Mochida K, Ito Y, Saito K, Nishino Y, Koike S, Kurimura T (1983). A clustering outbreak of hand, foot, and mouth disease caused by Coxsackie virus A10. Microbiol. Immunol. 27: 929-935.
113. Jarpe AJ, Hickman MR, Anderson JT, Winter WE, Peck AB (1990-1991). Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes. Reg. Immunol. 3: 305-317.
114. Jeurissen SH, Wagenaar F, Pol JM, van der Eb AJ, Noteborn MH (1992). Chicken anemia virus causes apoptosis of thymocytes after in vivo infection and of cell lines after in vitro infection. J. Virol. 66: 7383-7388.
115. Kadowaki N, Antonenko S, Lau JY, Liu YJ (2000). Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192: 219-226.
116. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P (1994). Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Sci. 265: 528-530.
117. Karvonen M, Pitkaniemi J, Tuomilehto J (1999). The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care. 22: 1066-70.
118. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ (1992). Autoimmunity to two forms of glutamate decarboxylase in insulin- dependent diabetes mellitus. J. Clin. Invest. 89: 283-292.
119. Kerr JF, Wyllie AH, Currie AR (1972). Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257.
120. Kim KA, Kim S, Chang I, Kim GS, Min YK, Lee MK, Kim KW, Lee MS (2002). IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis. Diabetologia 45: 385-393.
121. Kirkman HN, Gaetani GF (1984). Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH. Proc. Natl. Acad. Sci. USA. 81: 4343-4347.
122. Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ, Dorner AJ, Emini EA, Hanecak R, Lee JJ, van der Werf S, Anderson CW, Wimmer E (1981). Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 291: 547-553.
123. Koch F, Koch G (1985). Morphological alterations of the host cell as an essential basis for poliovirus replication. In "The Molecular Biology of Poliovirus" (eds. F.Koch and G.Koch), Springer-Verlag, Wien-New York. pp. 226-266
124. Korant BD (1973). Cleavage of poliovirus-specific polypeptide aggregates. J. Virol. 12: 556-563.
125. Kuyumcu-Martinez NM, Joachims M, Lloyd RE (2002). Efficient cleavage of ribosome associated poly(A)-binding protein by enterovirus 3C protease. J. Virol. 76: 2062-74.
126. Lansdown AB (1976). Pathological changes in the pancreas of mice following infection with coxsackie B viruses. Br. J. Exp. Pathol. 57: 331-338.
127. Larsson R, Cerutti P (1988). Oxidants induce phosphorylation of ribosomal protein S6. J. BiolChem. 263: 17452-17458.
128. Lemasters JJ (1999). V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am. J. Physiol. 276: G1-6.
129. Lennon SV, Martin SJ, Cotter TG (1991). Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 24: 203-214.
130. Lenzen S, Panten U (1988). Alloxan: history and mechanism of action. Diabetologia 31: 337-342.
131. Levy-Marchal C, Patterson C, Green A (1995). Variation by age group and seasonality at diagnosis of childhood IDDM in Europe. The EURODIAB ACE Study Group. Diabetologia 38: 823-830.
132. Liu D, Cardozo AK, Darville MI, Eizirik DL (2002). Double-stranded RNA cooperates with interferon-gamma and IL-1 beta to induce both chemokine expression and nuclear factorkappa B-dependent apoptosis in pancreatic beta-cells: potential mechanisms for viral-induced insulitis and beta-cell death in type 1 diabetes mellitus. Endocrinology 143: 1225-1234.
133. Liu X, Zou H, Slaughter C, Wang X (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175-84.
134. Livingstone C, Davis J (2007). Review: Targeting therapeutics against glutathione depletion in diabetes and its complications. Br. J. Diab. Vasc. Dis. 7: 258-265.
135. Lopez-Guerrero JA, Alonso M, Martin-Belmonte F, Carrasco L (2000). Poliovirus induces apoptosis in the human U937 promonocytic cell line. Virology 272: 250-256.
136. Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, Lenzen S (2000). Protection of insulin-producing RINm5F cells against cytokine- mediated toxicity through overexpression of antioxidant enzymes. Diabetes 49: 1123-1130.
137. Maeda H, Sawa T, Yubisui T, Akaike T (1999). Free radical generation from heterocyclic amines by cytochrome b5 reductase in the presence of NADH. Cancer Lett. 143: 117-121.
138. Maines MD (1997). The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37: 517-554.
139. Mandrup-Poulsen T (1996). The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39: 1005-1029.
140. Marselli L, Marchetti P, Tellini C, Giannarelli R, Lencioni C, Del Guerra S, Lupi R, Carmellini M, Mosca F, Navalesi R (2000). Lymphokine release from human lymphomononuclear cells after co-culture with isolated pancreatic islets: effects of islet species, long-term culture, and monocyte-macrophage cell removal. Cytokine 12: 503-505.
141. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF, Barnett AH (1997) Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 27: 484-490.
142. May JM, Qu ZC, Whitesell RR (1995). Ascorbate is the major electron donor for a transmembrane oxidoreductase of human erythrocytes. Biochim. Biophys. Acta. 1238: 127-136.
143. May JM, Qu ZC, Whitesell RR, Cobb CE (1996). Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate. Free Radic. Biol. Med. 20: 543-551.
144. Melnick JL (1996). Current status of poliovirus infections. Clin. Microbiol. Rev. 9: 293-300.
145. Mendiratta S, Qu ZC, May JM (1998). Enzyme-dependent ascorbate recycling in human erythrocytes: role of thioredoxin reductase. Free Radic. Biol. Med. 25: 221-228.
146. Miller BJ, Appel MC, O'Neil JJ, Wicker LS (1988). Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140: 52-58.
147. Molina TJ, Kishihara K, Siderovski DP, van Ewijk W, Narendran A, Timms E, Wakeham A, Paige CJ, Hartmann KU, Veillette A, Davidson D, Mak TW (1992). Profound block in thymocyte development in mice lacking p56lck. Nature 357: 161-164.
148. Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T, Matsuzawa Y (1999). Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus. Diabetologia 42: 1332-1340.
149. Muir P, van Loon AM (1997). Enterovirus infections of the central nervous system. Intervirol. 40: 153-166.
150. Nicholson DW, Thornberry NA (1997). Caspases: killer proteases. Trends Biochem. Sci. 22: 299-306.
151. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790.
152. Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, Maeda H (1989). Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244: 974-976.
153. Ohba M, Shibanuma M, Kuroki T, Nose K (1994). Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J. Cell Biol. 126: 1079-1088.
154. Op De Beeck A, Caillet-Fauquet P (1997). Viruses and the cell cycle. Prog. Cell Cycle Res. 3: 1-19.
155. Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric M, Trinidad C, Butcher, L, Chan J, Liu PP (2002). Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus- induced myocarditis. J. Clin. Invest. 109: 1561-1569.
156. Padaiga Z, Tuomilehto J, Karvonen M, Podar T, Brigis G, Urbonaite B, Kohtamaki K, Lounamaa R, Tuomilehto-Wolf E, Reunanen A (1997). Incidence trends in childhood onset IDDM in four countries around the Baltic sea during 1983-1992. Diabetologia 40: 187-192.
157. Perl A, Gergely P Jr, Puskas F, Banki K (2002). Metabolic switches of T- cell activation and apoptosis. Antioxid Redox Signal. 4: 427-443.
158. Peterhans E, Grob M, Burge T, Zanoni R (1987). Virus-induced formation of reactive oxygenintermediates in phagocytic cells. Free Radic. Res. Commun. 3: 39-46.
159. Petronilli V, Costantini P, Scorrano L, Colonna R, Passamonti S, Bernardi P (1994). The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidationreduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem. 269: 16638-16642.
160. Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, Oliver R, Fraker C, Ricordi C, Pastori RL, Bach FH, Inverardi L (2001). Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50: 1983-1991.
161. Pinkoski MJ, Waterhouse NJ, Heibein JA, Wolf BB, Kuwana T, Goldstein JC, Newmeyer DD, Bleackley RC, Green DR (2001). Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway. J. Biol. Chem. 276: 12060-12067.
162. Pipeleers D, Hoorens A, Marichal-Pipeleers M, Van de Casteele M, Bouwens L, Ling Z (2001). Role of pancreatic beta-cells in the process of beta-cell death. Diabetes 50(1): S52-57.
163. Platanias LC, Uddin S, Domanski P, Colamonici OR (1996). Differences in signaling between IFNs and: IFN selectively induces the interaction of the and L subunits of the Type I IFNR. J. Biol. Chem. 271: 23630-23633.
164. Pociot F, McDermott MF (2002). Genetics of type 1 diabetes mellitus. Genes Immun 3: 235-249.
165. Polla BS, Jacquier-Sarlin MR, Kantengwa S, Mariethoz E, Hennet T, Russo-Marie F, Cossarizza A (1996). TNF alpha alters mitochondrial membrane potential in L929 but not in TNF alpha-resistant L929.12 cells: relationship with the expression of stress proteins, annexin 1 and superoxide dismutase activity. Free Radic. Res. 25: 125-131.
166. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Lakey JR, Rajotte RV (1996b). Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J. Clin. Endocrinol. Metab. 81: 3197-3202.
167. Rabinovitch A, Suarez-Pinzon WL (1998). Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem. Pharmacol. 55: 1139-1149.
168. Racaniello VR (2001). Picornaviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds.) Fields Virol., 4th ed, Lippincott Williams and Wilkins, Philadelphia, USA. pp. 665-672.
169. Ramsingh AI (1997b). Coxcakieviruses and pancreatitis. Front. Biosci. 2: 53-62.
170. Ribeiro MM, Klein D, Pileggi A, Molano RD, Fraker C, Ricordi C., Inverardi L, Pastori RL (2003). Hemeoxygenase-1 fused to a TAT peptide transduces and protects pancreatic beta-cells. Biochem. Biophys. Res. Commun.305: 876-881.
171. Robertson RP (2004). Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279: 42351-42354.
172. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H (2003). Glucose toxicity in pancreatic islets beta cells: type-2 diabetes, good radicals gone bad and the glutathione connection. Diabetes 52: 581-587.
173. Rodriguez J, Lazebnik Y (1999). Caspase-9 and APAF-1 form an activeholoenzyme. Genes Dev. 13: 3179-3184.
174. Roep BO, Hiemstra HS, Schloot NC, De Vries RR, Chaudhuri A, Behan PO, Drijfhout JW (2002). Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann. NY Acad. Sci. 958: 163-165.
175. Roivainen M, Piirainen L, Hovi T, Virtanen I, Riikonen T, Heino J, Hyypia T (1994). Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 203: 357-365.
176. Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T (2002). Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 45: 693-702.
177. Romero-Alvira D, Roche E (1998). The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. Med. Hypotheses 51: 169-173.
178. Ronco LV, Karpova AY, Vidal M, Howley PM (1998). Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12: 2061-2072.
179. Rotbart HA (2002). Treatment of picornavirus infections. Antiviral Res. 53: 83-98.
180. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal regulating kinase (ASK) 1. EMBO J. 17: 2596-2606.
181. Samali A, Nordgren H, Zhivotovsky B, Peterson E, Orrenius S (1999). A comparative study of apoptosis and necrosis in HepG2 cells: oxidant- induced caspase inactivation leads to necrosis. Biochem. Biophys. Res. Commun. 255: 6-11.
182. Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana GE, Manto A, Ghirlanda G (1997). Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46: 1853-1858.
183. Santos CX, Anjos EI, Augusto O (1999). Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch. Biochem. Biophys. 372: 285-294.
184. Sawada M, Nakashima S, Kiyono T, Nakagawa M, Yamada J, Yamakawa H, Banno Y, Shinoda J, Nishimura Y, Nozawa Y, Sakai N (2001). Regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells. Oncogene 20: 1368-1378.
185. Schloot NC, Willemen SJ, Duinkerken G, Drijfhout JW, de Vries RR, Roep BO (2001). Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart. Hum. Immunol. 62: 299-309.
186. Schranz DB, Lernmark A (1998). Immunology in diabetes: an update. Diabetes Metab. Rev. 14: 3-29.
187. Schwarz KB (1996). Oxidative stress during viral infection: A review. Free Radic. Biol. Med. 21: 641-649.
188. Seghieri G, Martinoli L, di Felice M, Anichini R, Fazzini A, Ciuti M, Miceli M, Gaspa L, Franconi F (1998). Plasma and platelet ascorbate pools and lipid peroxidation in insulindependent diabetes mellitus. Eur. J. Clin. Invest. 28: 659-663.
189. Sies H, Stahl W, Sundquist AR (1992). Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids. Ann. NY. Acad. Sci. 669: 7-20.
190. Skinner KA, White CR, Patel R, Tan S, Barnes S, Kirk M, Darley-Usmar V, Parks DA (1998). Nitrosation of uric acid by peroxynitrite. Formation of a vasoactive nitric oxide donor. J. Biol. Chem. 273: 24491-24497.
191. Slee EA, Adrain C, Martin SJ (2001). Executioner caspase-3, -6, and -7 perform distinct, nonredundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276: 7320-7326.
192. Sofic E, Rustembegovic A, Kroyer G, Cao G (2002). Serum antioxidantcapacity in neurological, psychiatric, renal diseases and cardiomyopathy. J. Neural Transm. 109: 711-719.
193. Somersalo O (1955). Ann. Paediatr. Fenn. 1: 239-249.
194. Spector A, Yan GZ, Huang RR, McDermott MJ, Gascoyne PR, Pigiet V (1988). The effect of H2O2 upon thioredoxin-enriched lens epithelial cells. J. Biol. Chem. 263: 4984-4990.
195. Stadtman ER, Levine RL (2000). Protein oxidation. Ann. NY Acad. Sci. 899: 191-208.
196. Suarez-Pinzon WL, Szabo C, Rabinovitch A (1997). Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes 46: 907-911.
197. Sumida T, Furukawa M, Sakamoto A, Namekawa T, Maeda T, Zijlstra M, Iwamoto I, Koike T, Yoshida S, Tomioka H, Taniguchi M (1994). kPrevention of insulitis and diabetes in beta 2- microglobulin-deficient non-obese diabetic mice. Int. Immunol. 6: 1445-1449.
198. Sundaresan M, Yu ZX, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, Goldschmidt-Clermont PJ, Finkel T (1996). Regulation of reactive- oxygen-species generation in fibroblasts by Rac1. Biochem. J. 318 (Pt 2): 379-382.
199. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (1999). Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446.
200. Swanton C, Jones N (2001). Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products. Int. J. Exp. Pathol. 82: 3-13.
201. Tanaka N, Sato M, Lamphier MS, Nozawa H, Oda E, Noguchi S, Schreiber RD, Tsujimoto Y, Taniguchi T (1998). Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3: 29-37.
202. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV (1993). A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845-853.
203. Teodoro JG, Branton PE (1997). Regulation of apoptosis by viral gene products. J. Virol. 71: 1739-1746.
204. Thorsby E, Ronningen KS (1993). Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 371-377.
205. Tiedge M, Lortz S, Munday R, Lenzen S (1998). Complementary action of antioxidant enzymes in the protection of bioengineered insulin- producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 47: 1578-1585.
206. Tolskaya EA, Romanova LI, Kolesnikova MS, Ivannikova TA, Smirnova EA, Raikhlin NT, Agol VI (1995). Apoptosis-inducing and apoptosis- preventing functions of poliovirus. J. Virol. 69: 1181-1189.
207. Tracy S, Hofling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ (2000). Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J. Med. Virol. 62: 70-81.
208. Tsai EC, Hirsch IB, Brunzell JD, Chait A (1994). Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43: 1010-1014.
209. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio EA, Akerblom HK (1992). Epidemiology of childhood diabetes mellitus in Finland-background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 35: 70-76.
210. VanderJagt DJ, Harrison JM, Ratliff DM, Hunsaker LA, Vander Jagt DL (2001). Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin. Biochem. 34: 265-270.
211. Vaux DL, Weissman IL, Kim SK (1992). Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Sci. 258: 1955-1957.
212. Vessby J, Basu S, Mohsen R, Berne C, Vessby B (2002). Oxidative stress and antioxidant status in type 1 diabetes mellitus. J. Int. Med. 251: 69-76.
213. Viskari, H.R., Roivainen, M., Reunanen, A., Pitkaniemi, J., Sadeharju, K., Koskela, P., Hovi, T., Leinikki, P, Vilja, P, Tuomilehto, J, Hyoty, H (2002). Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes. 51: 2568-2571.
214. Vreugdenhil GR, Geluk A, Ottenhoff TH, Melchers WJ, Roep BO, Galama JM (1998). Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia 41: 40-46.
215. Whiteman M, Halliwell B (1996). Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants. Free Radic. Res. 25: 275-283.
216. Wicker LS, Leiter EH, Todd JA, Renjilian RJ, Peterson E, Fischer PA, Podolin PL, Zijlstra M, Jaenisch R, Peterson LB (1994). Beta 2- microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43: 500-504.
217. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr (1996). CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183: 67-76.
218. Xie B, Zhou JF, Lu Q, Li CJ, Chen P (2002a). Oxidative stress in patients with acute coxsackie virus myocarditis. Biomed. Environ. Sci. 15: 48-57.
219. Yoon JW, Austin M, Onodera T, Notkins AL (1979). Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300: 1173-1179.
220. Zou H, Li Y, Liu X, Wang X (1999). An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274: 11549-11556.